Bixiye
P73-25 Blue Cross Prior Authorization/Notification and Clinical Criteria Updates
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 3161 - 3170 ee natiijooyinka 4229
Bixiye
2025 December Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2025
Dukaamaysiga & Barashada
2026 Spanish Over the Counter (OTC) Allowance benefit Flex catalog
2026 Catálogo de Artículos de la Tarjeta Flex de Medicare de Venta Libre (OTC)
Bixiye
QP107-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Des 10, 2025
Bixiye
QP106-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Des 10, 2025
Bixiye
QP105-25 MHCP Pharmacy Benefit Exclusion for Azmiro™, Blenrep, Vistaseal™ kit, and Weed Mix Number 7B
Taariikhda uu dhaqangalayo Barnaamijka: Des 10, 2025
Bixiye
QP104-25 Commercial Pharmacy Benefit Exclusion for Azmiro™, Ospomyv™, Starjemza™, Vistaseal™ kit, and Weed Mix Number 7B
Taariikhda uu dhaqangalayo Barnaamijka: Des 10, 2025
Bixiye
QP103-25 PCA Agency and Community First Services and Supports Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Des 10, 2025
Bixiye
QP102-25 Prior Authorization and Notification Process for Early Intensive Behavioral Intervention (EIBI)/Early Intensive Developmental and Behavioral Intervention (EIDBI)
Taariikhda uu dhaqangalayo Barnaamijka: Des 10, 2025
Bixiye
QP101-25 Provider Press: Q4 2025
Taariikhda uu dhaqangalayo Barnaamijka: Des 10, 2025